Reteplase

Share on Facebook Share on Twitter Email
Drug Info:

Reteplase, r-PA

Top

Brand names: Retavase®



Reteplase (Recombinant) Solution for injection

What is this medicine?

RETEPLASE (RE te plays) is used to dissolve blood clots that form in certain blood vessels. This medicine is used when a blood clot in a heart artery causes a heart attack.
 
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.

What should I tell my health care provider before I take this medicine?

They need to know if you have any of these conditions:
•aneurysm
•bleeding problems or problems with blood clotting
•diabetic retinopathy or bleeding problems of the eye
•endocarditis (infection of the heart valves)
•head injury, brain disease, or tumor
•high blood pressure
•infection
•irregular heartbeats
•kidney disease
•liver disease
•mitral stenosis
•recent biopsy, childbirth, surgery, or trauma (injury)
•recent history of stroke
•stomach ulcer or bleeding ulcer•an unusual or allergic reaction to reteplase, other medicines, foods, dyes, or preservatives
•pregnant or trying to get pregnant
•breast-feeding

How should I use this medicine?

This medicine is for injection into a vein. It is usually given by a health care professional in a hospital or clinic setting.

Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.
NOTE: This medicine is only for you. Do not share this medicine with others.

What may interact with this medicine?

Do not take this medicine with any of the following medications:
•aminocaproic acid
•aprotinin
•tranexamic acid

This medicine may also interact with the following medications:
•antiplatelet drugs such as ticlopidine or clopidogrel
•aspirin and aspirin-like drugs
•medicines that treat or prevent blood clots like warfarin, heparin, enoxaparin, and dalteparin
•NSAIDs, medicines for pain and inflammation, like ibuprofen or naproxen

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medicine?

You will be closely monitored to check your progress after you receive this medicine. Follow the advice of your doctor or health care professional exactly. You may need bed rest to minimize the risk of bleeding.

This medicine can make you bleed more easily. This effect can last for several days. Try to avoid damage to your teeth and gums when you brush or floss your teeth, and try to avoid any other injury to yourself.

Do not take aspirin, ibuprofen, or other nonprescription pain relievers during or for several days after treatment with this medicine unless otherwise told to do so by your doctor or health care professional.

What side effects may I notice from receiving this medicine?

Side effects that you should report to your doctor or health care professional as soon as possible:
•allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
•blood in the urine, stools, or vomit
•breathing problems
•chest pain or tightness
•constipation or black tarry stools
•fever
•severe headache
•slow or fast heart rate
•unusual bleeding or bruising

Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
•dizziness, lightheadedness
•nausea, vomiting

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Where should I keep my medicine?

This drug is given in a hospital or clinic and will not be stored at home.

Last updated: 7/1/2002

Important Disclaimer: The drug information provided here is for educational purposes only. It is intended to supplement, not substitute for, the diagnosis, treatment and advice of a medical professional. This drug information does not cover all possible uses, precautions, side effects and interactions. It should not be construed to indicate that this or any drug is safe for you. Consult your medical professional for guidance before using any prescription or over the counter drugs.


A fibrinolytic drug used to dissolve blood clots in the coronary arteries (which supply the heart) in people who have had a heart attack; treatment should be started within 12 hours of the attack. Reteplase is available in a form for intravenous injection on prescription only.

Side effects, precautions, and interactions with other drugs:
see fibrinolytic drugs.

Proprietary preparation:
Rapilysin.

Previous:retapamulin, repaglinide, remifentanil
Next:retinoids, ribavirin, riboflavin
Reteplase
File:Reteplase.png
Clinical data
Trade names Retavase
AHFS/Drugs.com monograph
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 133652-38-7 YesY
ATC code B01AD07
DrugBank DB00015
UNII DQA630RIE9 YesY
KEGG D05721 YesY
Chemical data
Formula C1736H2671N499O522S22 
Mol. mass 39589.6 g/mol
 YesY (what is this?)  (verify)

Reteplase (trade names Retavase, Rapilysin) is a thrombolytic drug, used to treat heart attacks by breaking up the clots that cause them.

Reteplase is a recombinant non-glycosylated form of human tissue plasminogen activator, which has been modified to contain 357 of the 527 amino acids of the original protein. It is produced in the bacterium Escherichia coli.

Reteplase is similar to recombinant human tissue plasminogen activator (alteplase), but the modifications give reteplase a longer half-life of 13–16 minutes. Reteplase also binds fibrin with lower affinity than alteplase, improving its ability to penetrate into clots.

Reteplase was approved by the Food and Drug Administration in 1996.

As reteplase is able to penetrate inside the thrombi, an enhanced fibrinolytic activity will be achieved → rapid reperfusion → low incidence of bleeding.



Post a question - any question - to the WikiAnswers community:

Copyrights: